Female Fertility Cryopreservation Outcomes in Childhood Cancer: A Systematic Review

What this review examined

This systematic review pooled outcomes from 12 studies involving 612 female childhood cancer patients who underwent fertility preservation 0:20. Of these, 501 had ovarian tissue cryopreserved before gonadotoxic therapy 0:26. The central question: what proportion of these girls ultimately achieved pregnancy and live birth after tissue transplantation?

The conversion funnel

Only 30 of the 501 patients who had tissue preserved went on to receive ovarian tissue transplantation — a 6% utilization rate 0:31. Among those 30 who received transplants, 9 became pregnant 0:36. Of those 9 pregnancies, 6 resulted in live birth 0:40. Viewed from the transplant cohort, that represents a 30% pregnancy rate and a 67% live birth rate among those who conceived. Viewed from the original cryopreservation cohort, a small minority of preserved patients achieved live birth in this dataset.

What the numbers mean

The high live birth rate among those who became pregnant (67%) is encouraging 0:40. The low transplantation rate (6%) reflects multiple realities: many patients may still be too young to have attempted transplantation, some may have chosen other fertility options or no intervention, some may not have survived their malignancy, and some may have retained ovarian function and not required transplantation. The review does not parse these categories.

The gap

Cecilia Jigena, presenting this work from Cincinnati Children's, emphasizes that despite these preliminary successes, "we still need more high quality studies to understand it better and improve its outcomes" [q3] 0:43. The current evidence base spans only 12 studies with heterogeneous populations, variable follow-up, and limited long-term data on the children born from transplanted tissue.

What this means for counseling

For oncologists and surgeons discussing fertility preservation with families facing gonadotoxic therapy, this review provides the most comprehensive outcome data available but also underscores the uncertainty. Ovarian tissue cryopreservation is feasible and can result in live birth, but the pathway from preservation to parenthood remains incompletely mapped, and the denominator of patients who will ultimately benefit is still unknown.